Detalhe da pesquisa
1.
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.
Immunity
; 55(12): 2405-2418.e7, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356572
2.
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses.
Immunity
; 54(4): 769-780.e6, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823129
3.
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin.
Immunity
; 51(2): 398-410.e5, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350180
4.
Quadrivalent influenza nanoparticle vaccines induce broad protection.
Nature
; 592(7855): 623-628, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762730
5.
Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
J Infect Dis
; 219(Suppl_1): S107-S109, 2019 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715413
6.
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Sci Transl Med
; 15(692): eade4790, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075129
7.
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines.
NPJ Vaccines
; 7(1): 124, 2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289232
8.
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.
Sci Transl Med
; 14(676): eade0424, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542692
9.
Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.
Sci Transl Med
; 14(650): eabo5032, 2022 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731888
10.
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.
Nat Med
; 28(2): 383-391, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115706
11.
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies.
Nat Commun
; 12(1): 1722, 2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741916
12.
Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.
Sci Transl Med
; 13(583)2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33658355
13.
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial.
Lancet Respir Med
; 9(10): 1111-1120, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864736
14.
Next-generation influenza vaccines: opportunities and challenges.
Nat Rev Drug Discov
; 19(4): 239-252, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32060419
15.
Author Correction: Next-generation influenza vaccines: opportunities and challenges.
Nat Rev Drug Discov
; 19(6): 427, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32494049
16.
Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses.
Nat Commun
; 11(1): 791, 2020 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034141
17.
Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.
mBio
; 10(1)2019 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30808695
18.
A proof of concept for structure-based vaccine design targeting RSV in humans.
Science
; 365(6452): 505-509, 2019 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371616
19.
Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera.
Sci Rep
; 8(1): 8628, 2018 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29872070
20.
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.
NPJ Vaccines
; 2: 15, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263871